Log in to save to my catalogue

Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model

Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_90e75c54ea4c45dc88726228f3ff93a7

Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model

About this item

Full title

Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model

Publisher

Switzerland: MDPI AG

Journal title

Biomedicines, 2022-02, Vol.10 (2), p.405

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Background: Autism spectrum disorder (ASD) is a lifelong neurodevelopmental disorder affecting about 1.5% of children, and its prevalence is increasing. Anxiety is one of the most common comorbid signs of ASD. Despite the increasing prevalence, the pathophysiology of ASD is still poorly understood, and its proper treatment has not been defined yet....

Alternative Titles

Full title

Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_90e75c54ea4c45dc88726228f3ff93a7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_90e75c54ea4c45dc88726228f3ff93a7

Other Identifiers

ISSN

2227-9059

E-ISSN

2227-9059

DOI

10.3390/biomedicines10020405

How to access this item